glp-1 and migraine Could a Drug Cut Your Days in Half? Research Says Yes GLP-1 medications have become one

Weighing the Risks: Small Bowel Obstruction Associated With Semaglutide Use in the [PMID: 40861748] Laboratory literature summary: Weighing the Risks: Small Bowel Obstruction Associated With Semaglutide Use in the Postoperative Abdomen

ISBN 978-0-07-146690-5

These medications slow gastric emptying, meaning food remains in the stomach longer before moving into the small intestine

Changes in energy expenditure resulting from altered body weight

GLP-1 receptor agonists have also shown success in other therapeutic areas apart from type 2 diabetes and obesity, in particular for non-alcoholic fatty liver disease [104]